KIDNEY HEALTH INITIATIVE URGES THE ACCELERATION OF HOME THERAPY TECHNOLOGY IN RESPONSE TO CORONAVIRUS 2019 (COVID-19)

The COVID-19 pandemic highlights the vulnerability of people with kidney failure who rely on in-center hemodialysis. People with kidney failure are at high risk of severe COVID-19 complications and are exposed to infection due to a kidney replacement therapy process that requires traveling to a dialysis facility multiple times a week.

Read more

Sedative Drug in Combination with Opioids May Be Especially Dangerous

• In an analysis of information on US adults initiating hemodialysis, 16% of patients were dispensed a short-acting benzodiazepine, and approximately one-quarter of these patients were also dispensed opioids.
• Among patients with an opioid prescription, being dispensed a short-acting benzodiazepine had a 1.9-fold higher risk of dying over a median follow-up of 16 months compared with patients without a short-acting benzodiazepine.

Read more

HOUSE ENERGY AND COMMERCE COMMITTEE HOLDS HEARING ON IMMUNOSUPPRESSIVE DRUG COVERAGE, A KEY LEGISLATIVE PRIORITY OF AMERICAN SOCIETY OF NEPHROLOGY

Washington, DC (January 8, 2020) — The House Energy and Commerce Committee is scheduled to hold a hearing on Wednesday, January 8, on the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019, advancing a long-standing legislative priority of the American Society of Nephrology.

Read more

Careful Monitoring of Children Following Cardiac Surgery May Improve Long-Term Outcomes

In a medical records study covering thousands of children, a U.S.-Canadian team led by researchers at Johns Hopkins Medicine concludes that while surgery to correct congenital heart disease (CHD) within 10 years after birth may restore young hearts to healthy function, it also may be associated with an increased risk of death and kidney failure within a few months or years after surgery.

Read more